Patients receiving sitagliptin with metformin and glimepiride had significant improvements in A1C and FPG compared to patients receiving placebo with metformin and glimepiride (Table 11), with mean reductions from baseline relative to placebo in A1C of -0.9% and in FPG of -21 mg/dL
One dose per week
The scientific evidence supporting liposomal glutathione continues to grow, demonstrating its advantages in bioavailability, cellular uptake, and overall effectiveness
As one of the most abundant intracellular antioxidants, Glutathione participates in numerous biochemical processes associated with cellular protection, metabolic regulation, and oxidative stress response
Less common but clinically significant adverse effects include hypoglycaemia (particularly when used alongside insulin or sulphonylureas), acute pancreatitis, gallbladder disorders, and hypersensitivity reactions